Overview

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

Status:
Not yet recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This study evaluate the pharmacokinetic drug interactions and safety after co-administration of ilaprazole and NSAID in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Il-Yang Pharm. Co., Ltd.
Treatments:
Aceclofenac
Celecoxib
Naproxen